Azenta(AZTA) - 2024 Q4 - Annual Results

Exhibit 99.1 Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO ● FY'24 revenue growth of 4%, reported and organic, in combined Sample Management Solutions and Multiomics ● FY'25 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis points ● Pursuing a sale of B Medical Systems to simplify portfolio and drive revenue growth and profitability ...